(HealthDay)—Optimal management of subtherapeutic international normalized ratios (INRs) is unclear, with differences in bridging practices among pharmacists seen for levels of experience, residency training, and prescribing ...
Jun 23, 2015
0
3
(HealthDay)—Recommendations have been issued for the use of direct oral anticoagulants (DOACs) in obese patients; the guideline was published online March 22 in the Journal of Thrombosis and Haemostasis.
Apr 12, 2016
0
2
New research presented this week at ACR Convergence 2022, the American College of Rheumatology's annual meeting, found that adult RA patients starting opioids had twice the risk of venous thromboembolism (VTE) compared to ...
Nov 8, 2022
0
31
Obese women who used oral contraceptives appeared to have increased risk for a rare type of stroke known as a cerebral venous thrombosis (CVT) compared with women of normal weight who did not use oral contraceptives, according ...
Mar 14, 2016
0
1
Researchers from Boston University School of Medicine (BUSM) have found that the use of Inferior Vena Cava (IVC) filters for the prevention and treatment of venous thrombotic events (VTE) may result in poor outcomes due to ...
Mar 18, 2013
0
0
(HealthDay)—For men with prostate cancer (PC), the rate of venous thromboembolism (VTE) is increased with high comorbidity, according to a study published online July 6 in Cancer.
Jul 21, 2015
0
10
The longer the duration of surgery, the higher the risk of a life-threatening blood clot, according to the first large-scale, quantitative national study of the risk across all surgical procedures.
Dec 3, 2014
0
0
(HealthDay)—The first oral blood thinning medication for children was approved by the U.S. Food and Drug Administration, the agency announced Monday.
Jun 23, 2021
0
3
(HealthDay)—Rivaroxaban does not lower risk of symptomatic venous thromboembolism and related death in medical patients after hospital discharge, compared to placebo, according to a study published in the Sept. 20 issue ...
Sep 20, 2018
0
0
(HealthDay)—Reducing factor XI levels with a second-generation antisense oligonucleotide (FXI-ASO) is effective for preventing venous thromboembolism after total knee arthroplasty, according to a study published online ...
Dec 8, 2014
0
0
